Cargando…
_version_ 1784840234235592704
author Lee, Lui Shiong
Sim, Adelene Y. L.
Ong, Chee Wee
Yang, Xinyan
Ng, Cedric C. Y.
Liu, Wei
Rajasegaran, Vikneswari
Lim, Abner M. S.
Aslim, Edwin Jonathan
Ngo, Nye-Thane
Khor, Li-Yan
Kanesvaran, Ravindran
Allen, John Carson Jr
Tay, Kae Jack
Yuen, John Shyi Peng
Chong, Tsung Wen
Ho, Sun Sien Henry
Teh, Bin Tean
Chua, Melvin L. K.
author_facet Lee, Lui Shiong
Sim, Adelene Y. L.
Ong, Chee Wee
Yang, Xinyan
Ng, Cedric C. Y.
Liu, Wei
Rajasegaran, Vikneswari
Lim, Abner M. S.
Aslim, Edwin Jonathan
Ngo, Nye-Thane
Khor, Li-Yan
Kanesvaran, Ravindran
Allen, John Carson Jr
Tay, Kae Jack
Yuen, John Shyi Peng
Chong, Tsung Wen
Ho, Sun Sien Henry
Teh, Bin Tean
Chua, Melvin L. K.
author_sort Lee, Lui Shiong
collection PubMed
description
format Online
Article
Text
id pubmed-9705234
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-97052342022-11-30 Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer Lee, Lui Shiong Sim, Adelene Y. L. Ong, Chee Wee Yang, Xinyan Ng, Cedric C. Y. Liu, Wei Rajasegaran, Vikneswari Lim, Abner M. S. Aslim, Edwin Jonathan Ngo, Nye-Thane Khor, Li-Yan Kanesvaran, Ravindran Allen, John Carson Jr Tay, Kae Jack Yuen, John Shyi Peng Chong, Tsung Wen Ho, Sun Sien Henry Teh, Bin Tean Chua, Melvin L. K. Prostate Cancer Prostatic Dis Correction Nature Publishing Group UK 2022-03-14 2022 /pmc/articles/PMC9705234/ /pubmed/35288663 http://dx.doi.org/10.1038/s41391-022-00522-9 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Lee, Lui Shiong
Sim, Adelene Y. L.
Ong, Chee Wee
Yang, Xinyan
Ng, Cedric C. Y.
Liu, Wei
Rajasegaran, Vikneswari
Lim, Abner M. S.
Aslim, Edwin Jonathan
Ngo, Nye-Thane
Khor, Li-Yan
Kanesvaran, Ravindran
Allen, John Carson Jr
Tay, Kae Jack
Yuen, John Shyi Peng
Chong, Tsung Wen
Ho, Sun Sien Henry
Teh, Bin Tean
Chua, Melvin L. K.
Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
title Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
title_full Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
title_fullStr Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
title_full_unstemmed Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
title_short Correction to: NEAR trial: A single-arm phase II trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
title_sort correction to: near trial: a single-arm phase ii trial of neoadjuvant apalutamide monotherapy and radical prostatectomy in intermediate- and high-risk prostate cancer
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705234/
https://www.ncbi.nlm.nih.gov/pubmed/35288663
http://dx.doi.org/10.1038/s41391-022-00522-9
work_keys_str_mv AT leeluishiong correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT simadeleneyl correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT ongcheewee correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT yangxinyan correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT ngcedriccy correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT liuwei correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT rajasegaranvikneswari correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT limabnerms correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT aslimedwinjonathan correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT ngonyethane correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT khorliyan correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT kanesvaranravindran correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT allenjohncarsonjr correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT taykaejack correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT yuenjohnshyipeng correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT chongtsungwen correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT hosunsienhenry correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT tehbintean correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer
AT chuamelvinlk correctiontoneartrialasinglearmphaseiitrialofneoadjuvantapalutamidemonotherapyandradicalprostatectomyinintermediateandhighriskprostatecancer